Impact of systemic targeted agents on the clinical outcomes of patients with brain metastases.
Johnson AG, Ruiz J, Hughes R, Page BR, Isom S, Lucas JT, McTyre ER, Houseknecht KW, Ayala-Peacock DN, Bourland DJ, Hinson WH, Laxton AW, Tatter SB, Debinski W, Watabe K, Chan MD.
Johnson AG, et al.
Oncotarget. 2015 Aug 7;6(22):18945-55. doi: 10.18632/oncotarget.4153.
Oncotarget. 2015.
PMID: 26087184
Free PMC article.